These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Allergy-related polymorphisms influence glioma status and serum IgE levels. Wiemels JL; Wiencke JK; Kelsey KT; Moghadassi M; Rice T; Urayama KY; Miike R; Wrensch M Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1229-35. PubMed ID: 17548690 [TBL] [Abstract][Full Text] [Related]
44. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574 [TBL] [Abstract][Full Text] [Related]
45. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis. Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103 [TBL] [Abstract][Full Text] [Related]
46. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy. da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252 [TBL] [Abstract][Full Text] [Related]
47. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Bethke L; Webb E; Murray A; Schoemaker M; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Swerdlow A; Houlston R Hum Mol Genet; 2008 Mar; 17(6):800-5. PubMed ID: 18048407 [TBL] [Abstract][Full Text] [Related]
48. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis. Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196 [TBL] [Abstract][Full Text] [Related]
49. Additional evidence supports association of common genetic variants in VTI1A and ETFA with increased risk of glioma susceptibility. Wang N; Deng Z; Wang M; Li R; Xu G; Bao G J Neurol Sci; 2017 Apr; 375():282-288. PubMed ID: 28320150 [TBL] [Abstract][Full Text] [Related]
50. The ErbB/HER family of protein-tyrosine kinases and cancer. Roskoski R Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963 [TBL] [Abstract][Full Text] [Related]
51. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Liu Y; Shete S; Wang LE; El-Zein R; Etzel CJ; Liang FW; Armstrong G; Tsavachidis S; Gilbert MR; Aldape KD; Xing J; Wu X; Wei Q; Bondy ML Carcinogenesis; 2010 Oct; 31(10):1762-9. PubMed ID: 20610542 [TBL] [Abstract][Full Text] [Related]
52. A meta-analysis study of the association between EGFR rs2252586 mutation and the risk of glioma. Xin Y; Han FG; Chen D; Chen J; Fang CX; Lou L; Liu H Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):116-118. PubMed ID: 29208187 [TBL] [Abstract][Full Text] [Related]
53. Heritable variation of ERBB2 and breast cancer risk. Breyer JP; Sanders ME; Airey DC; Cai Q; Yaspan BL; Schuyler PA; Dai Q; Boulos F; Olivares MG; Bradley KM; Gao YT; Page DL; Dupont WD; Zheng W; Smith JR Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1252-8. PubMed ID: 19336545 [TBL] [Abstract][Full Text] [Related]
54. Updated Insights on EGFR Signaling Pathways in Glioma. Oprita A; Baloi SC; Staicu GA; Alexandru O; Tache DE; Danoiu S; Micu ES; Sevastre AS Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435537 [TBL] [Abstract][Full Text] [Related]
56. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278 [TBL] [Abstract][Full Text] [Related]
58. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697 [TBL] [Abstract][Full Text] [Related]
59. The Histone Demethylase NO66 Induces Glioma Cell Proliferation. Wang Q; Liu PY; Liu T; Lan Q Anticancer Res; 2019 Nov; 39(11):6007-6014. PubMed ID: 31704826 [TBL] [Abstract][Full Text] [Related]
60. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas. Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]